Document wgEMqrevQDx3gGVG41pnydybD
.
APmE
REA
AAANSNOACIATTIOON ROF TFANT nent
WG ERT ef r y
VIA OVERNIGHT DELIVERY
Document Processing Center (7407)
UO.fSf.icEenovfiProolnlmuetnitoanlPPrreovteencttiioonn aAngdeTnocxyics
401 M Street SW
Washington, D.C. 20460
AR 22 6 - sz
BEHR-0102 _ 14596
-
=
8
38 W3W3
Direct Tel
+44 1928 513953
Direct Fax
Email
+44 1928511587 david famar@ineoschlor.com
Date
11*January 2002
2 38 a
Attention: ForYourInformationDocket -Docket No.AR-226
Re: `Ammonium Perfluorooctanoate
Dear Sir or Madam:
final reTpohretsAscsoonccieartniionng oafn PolraasltitcosxiMcaintuyfsatcutduyreorfs aimn mEounrioupem (pAerPfMlEuo)rohoacstarneocaetieveidn rmaonngkee-yfsi.ndin`gWestuadrye aenndclaonsailnygtictahle wroerpko,rtassofnolltohwes:full study, and the accompanying
PFeinraflluorRoeopcotratn,oate26(-AWPeFeOk)
inCapCsyunloemolTgouxsiciMtoynkeySst,udyCovawintche
Ammonium
Laboratories,
December 18, 2001
Final Report 4-Week Capsule Toxicity Suwdy with Ammonium
DPeercfelmuobreoroc1t8a,n2oa0t0e1 (APFO) in Cynomolgus Monkeys, Covance Laboratories,
Final Report, Determination of the Presence and Concentration of
Perfluorooctanoate Fluorochemical in Liver, Serum, Urine and FecesSamples, 3M Environmental Laboratory and Centre Analytical Laboratories, Inc., June 11, 2001.
`The enclosed reportsare in PDF format on compact disc.
nnI | an |
BEHR-99-14596
AVENUY FE. VAN NIKUWINIOYSE 73 Bo 310m Moses
=
== Eo
Ses&
= 538
====O
= = a
t1h9e99d,ralEWlPerAepnooRrtetef.ofonrNtyoh.oiusrs8rtEeuHfdQey-re1tn1oc9et9ht-eh1a4tT5S39CM6A,prSeaevncidtoiuoshnlays8(sua)lbsmDoioctskeaedbtma onnotiNceecownecnertni1n9g,
information on the study to this AR-226 docket
isten preliminary
Please fecl free to contact me with any questions. 7 Ta.
CDhaaviird Farra0r AAsds-ohcoicatAioPnoFfOPTloaxstiiccosloMgaynuWfoarcktuirnegrsGrion uEpurope ce: DDrr.. COhsacralresHeAmuaengdea